ArticleG3 (Bethesda, Md.)2025
The transsulfuration pathway suppresses the embryonic lethal phenotype of glutathione reductase mutants in Caenorhabditis elegans.
Marina Valenzuela-Villatoro, Eva Gómez-Orte, David Guerrero-Gómez, Qing Cheng, Angelina Zheleva, José Antonio Mora-Lorca, Dunja Petrovic, Nigel J O Neil, Julián Cerón, Akiko Hatakeyama and 8 more
Abstract read
In one paragraphArticle in G3 (Bethesda, Md.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Marina Valenzuela-VillatoroRedox Homeostasis Group, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0001-5601-9462 Eva Gómez-OrteDepartamento de Oncología, Centro de Investigación Biomédica de la Rioja, 26006 Logroño, Spain.ORCID 0000-0001-6802-1746 David Guerrero-GómezRedox Homeostasis Group, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0001-9403-6431 Qing ChengDivision of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID 0000-0002-3170-9333 Angelina ZhelevaDepartamento de Oncología, Centro de Investigación Biomédica de la Rioja, 26006 Logroño, Spain.ORCID 0000-0002-6898-6289 José Antonio Mora-LorcaRedox Homeostasis Group, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0003-0389-8744 Nigel J O NeilMichael Smith Laboratories, University of British Columbia, V6T 1Z4 Vancouver, Canada.ORCID 0000-0002-1992-6976 Julián CerónModeling Human Diseases in C. elegans Group; Genes, Diseases, and Therapies Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.ORCID 0000-0003-4739-2243 Akiko HatakeyamaLaboratory for Developmental Dynamics, RIKEN Center for Biosystems Dynamics Research, 650-0047 Kobe, Japan.ORCID 0009-0001-4652-3179 Shuichi OnamiLaboratory for Developmental Dynamics, RIKEN Center for Biosystems Dynamics Research, 650-0047 Kobe, Japan.ORCID 0000-0002-8255-1724 Alexandra Ordóñez-LuqueRedox Homeostasis Group, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0009-0002-9684-949X Cristina AyusoAndalusian Centre for Developmental Biology, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Pablo de Olavide, Junta de Andalucía, 41013 Seville, Spain.ORCID 0000-0002-7179-4309 Peter AskjaerAndalusian Centre for Developmental Biology, Consejo Superior de Investigaciones Científicas (CSIC), Universidad Pablo de Olavide, Junta de Andalucía, 41013 Seville, Spain.ORCID 0000-0003-3192-4428 Elias S J ArnérDivision of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 17177 Stockholm, Sweden.ORCID 0000-0002-4807-6114 Juan CabelloDepartamento de Oncología, Centro de Investigación Biomédica de la Rioja, 26006 Logroño, Spain.ORCID 0000-0002-3835-0116 Antonio Miranda-VizueteRedox Homeostasis Group, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.ORCID 0000-0002-6856-5396 Funding
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5MFEDER CEX2020-001088-MFEDER DOC_01674FEDER MICIU/AEI/10.13039/501100011033FEDER P20_00229FEDER PAIDI 2020FEDER PID2022-137162NB-I00MV-V, DG-G, EG-O, JC, and AM-V MICIU/AEI/10.13039/501100011033MV-V, DG-G, EG-O, JC, and AM-V PGC2018-094276-B-I00MV-V, DG-G, EG-O, JC, and AM-V PID2021-122311NB-I00MV-V, DG-G, EG-O, JC, and AM-V PID2021-127388NB-I00NIH HHS P40 OD010440
6 · The paper itselfAbstract
The gsr-1 gene encodes the only glutathione reductase in Caenorhabditis elegans and gsr-1 loss-of-function alleles have a fully penetrant embryonic lethal phenotype. Therefore, maintenance of glutathione redox homeostasis is essential for nematode survival. We report here that impairment of the nonsense-mediated mRNA decay (NMD) pathway suppresses the embryonic lethality of gsr-1 mutants, allowing their normal development and growth. This NMD pathway dependent suppression requires cth-1 and cth-2 that encode 2 isoforms of cystathionine-γ-lyase that catalyze the conversion of cystathionine to cysteine through the transsulfuration pathway. In contrast, the thioredoxin system that can also provide cysteine through the cystine reduction pathway appears to be dispensable for the suppression of the lethal phenotype of gsr-1 embryos when the NMD pathway is inactivated. Together, our data indicate that increasing the activity of the reverse transsulfuration pathway can compensate the detrimental effect of the gsr-1 mutation, raising the interesting question of why C. elegans has not preserved such compensatory mechanism to avoid the embryonic lethality of these mutants.
Indexed as
Caenorhabditis elegansCaenorhabditis elegans ProteinsGlutathione ReductaseMutationAnimalsEmbryo, NonmammalianGenes, LethalNonsense Mediated mRNA DecayPhenotypeCaenorhabditis elegans ProteinsGlutathione ReductasecysteinecystineglutathioneNMD pathwaysmg genestranssulfuration
Identifiers
PMID40333285
PMCPMC12341920
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390